# Pfizer Q3 Earnings Beat

> Pfizer reports stronger-than-expected Q3 FY26 earnings and raises full-year guidance.
- Title: Pfizer Q3 Earnings Beat | Shortify
- Summary: Pfizer reports stronger-than-expected Q3 FY26 earnings and raises full-year guidance. Pfizer's Q3 FY26 earnings per share beat estimates at $0.87, with…
- Keywords: pfizer, fy26, earnings, revenue, guidance, Alphastreet - Earnings Decoded. Market Intelligence Delivered
- Source: Alphastreet - Earnings Decoded. Market Intelligence Delivered — https://news.alphastreet.com/pfizer-pfe-q3-fy26-earnings-beat-estimates-raises-fy26-guidance
- Author: Staff Editor 2
- Published: 2026-11-03T20:47:01+00:00
- Read time: 1 min
- Topics: pfizer, q3, fy26, earnings, revenue, guidance
## Q3 Financial Results
Pfizer reported stronger-than-expected third-quarter earnings for fiscal 2026 with revenue of $16.58 billion, slightly down from the prior-year quarter.
## Earnings Per Share
Adjusted earnings per share reached $0.87, beating analyst estimates, while reported net income declined to $3.24 billion.
## Full-Year Guidance
Pfizer raised its full-year 2026 revenue guidance by $1.5 billion to $62.0-$64.0 billion and narrowed adjusted earnings per share guidance to $2.95-$3.05.
## Key takeaway

Pfizer's Q3 FY26 earnings per share beat estimates at $0.87, with adjusted revenue of $16.58 billion and raised full-year 2026 revenue guidance to $62.0-$64.0 billion.